Application
Western blot analysis of DYRK1A Antibody (N-term) in 293 cell line lysates (35ug/lane). DYRK1A (arrow) was detected using the purified Pab.
Application
DYRK1A Antiboty (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human prostate carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the DYRK1A Antiboty (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.